Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
Active, not recruiting · NCT06984094 · Registry updated 2026-05-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults | Human MetapneumoVirus Infection, Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-20 | NCT06984094 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Clover Biopharmaceuticals AUS Pty | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fusion Clinical Research | Adelaide | Australia | 1 |
| Linear Clinical Research | Perth | Australia | 12 |
| Paratus Clinical Research | Melbourne | Australia | 1 |